cAMP/PKA signaling defects in tumors: genetics and tissue-specific pluripotential cell-derived lesions in human and mouse.
about
Harnessing protein kinase A activation to induce mesenchymal-epithelial programs to eliminate chemoresistant, tumor-initiating breast cancer cellsProtein kinases as switches for the function of upstream stimulatory factors: implications for tissue injury and cancerGermline PRKACA amplification causes variable phenotypes that may depend on the extent of the genomic defect: molecular mechanisms and clinical presentations.In-vivo detection of binary PKA network interactions upon activation of endogenous GPCRsCholesterol Biosynthesis and Trafficking in Cortisol-Producing Lesions of the Adrenal Cortex.Mouse models of adrenocortical tumors.Constitutive activation of PKA catalytic subunit in adrenal Cushing's syndrome.Phosphodiesterases and adrenal Cushing in mice and humans.The G protein Gαs acts as a tumor suppressor in sonic hedgehog signaling-driven tumorigenesis.Diagnosis and Clinical Genetics of Cushing Syndrome in Pediatrics.cAMP-specific PDE4 phosphodiesterases and AIP in the pathogenesis of pituitary tumors.Carney complex and McCune Albright syndrome: an overview of clinical manifestations and human molecular genetics.Adrenal cancer in 2013: Time to individualize treatment for adrenocortical cancer?Temporal and spatial regulation of cAMP signaling in disease: role of cyclic nucleotide phosphodiesterases.Impact of kinase activating and inactivating patient mutations on binary PKA interactions.Differential expression of the protein kinase A subunits in normal adrenal glands and adrenocortical adenomas.E pluribus unum? The main protein kinase A catalytic subunit (PRKACA), a likely oncogene, and cortisol-producing tumors.Cyclic AMP-dependent protein kinase catalytic subunit A (PRKACA): the expected, the unexpected, and what might be next.Age-dependent effects of Armc5 haploinsufficiency on adrenocortical function.Three cases of thyroid cancer following the diagnosis of testicular cancer: treatment-related complication or genetics?
P2860
Q33865464-BD0110F7-0344-4716-90FB-B90D238536ACQ35094487-75AE922A-A685-49E4-B79A-C75A47279B57Q35595823-BDC61578-EB69-4F33-8A88-8B778B9CE108Q35769802-541E47B0-0668-4685-B972-3DFCA2792DE8Q36129799-C4C2C421-B6E2-475F-BE95-A119C21AB010Q36482758-FA8DC2D4-C63C-4AA4-A710-EDDCADEB0FCBQ36503929-2CF96729-84B0-420A-A557-7C1884BC81D7Q36514530-5E9B9C1E-361C-4E33-91F0-0A5A94BBC8BCQ36956892-AA553602-75B3-42EB-B6A3-41EBC3EFEA21Q36958893-BDF6A5D7-7252-4015-ADCD-D6DA092F5DFFQ36991419-02C277EA-1541-4536-AFB0-CD53D6409CECQ37619451-C34F3240-3DEE-4D98-8DAA-C3EEE7BE7EFEQ38176150-84E14AB4-D9FC-42D6-B8CD-8F740A54A2A6Q38205932-C7CDF2F8-C28A-4FC0-A58C-BA892EC773E0Q41815705-B42C6CFD-7695-48A7-86CD-AAC3B64215CDQ42053452-0A1C4589-2B2E-4CC2-A58E-9B97C1568BA2Q42547576-DCC136C6-82DA-45EE-8B64-11C3287D8596Q47174516-FBC1CBD7-22DC-4D66-9552-195DB6A3E75AQ47801106-FF8F0E8B-3E97-4BFE-930C-B5B94B0E0958Q53124317-C54C431C-20B0-41F0-91A4-EB55DA78D51A
P2860
cAMP/PKA signaling defects in tumors: genetics and tissue-specific pluripotential cell-derived lesions in human and mouse.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
cAMP/PKA signaling defects in ...... ed lesions in human and mouse.
@ast
cAMP/PKA signaling defects in ...... ed lesions in human and mouse.
@en
type
label
cAMP/PKA signaling defects in ...... ed lesions in human and mouse.
@ast
cAMP/PKA signaling defects in ...... ed lesions in human and mouse.
@en
prefLabel
cAMP/PKA signaling defects in ...... ed lesions in human and mouse.
@ast
cAMP/PKA signaling defects in ...... ed lesions in human and mouse.
@en
P2860
P1476
cAMP/PKA signaling defects in ...... ed lesions in human and mouse.
@en
P2860
P304
P356
10.1016/J.MCE.2013.01.015
P577
2013-02-26T00:00:00Z